Predictive value of symptoms for early detection of ovarian cancer

Journal of the National Cancer Institute

Volumn 102, Issue 4, 2010, Pages 222-229

  Rossing, Mary Anne ^a,b   Wicklund, Kristine G ^a   Cushing Haugen, Kara L ^a   Weiss, Noel S ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; CANCER INVASION; CANCER STAGING; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; OVARY CANCER; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINARY FREQUENCY; URINARY URGENCY;

ABDOMINAL PAIN; ADULT; AGE FACTORS; AGED; CARCINOMA; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; WASHINGTON;

EID: 77649263282     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp500     Document Type: Article

References (24)

1. Goff BA, Mandel LS, Melancon CH, et al. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705- 2712.
2. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221-227.
3. Olson SH, Mignone L, Nakraseive C, et al. Symptoms of ovarian cancer. Obstet Gynecol. 2001;98(2):212-217.
4. Vine MF, Ness RB, Calingaert B, et al. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol. 2001;83(3):466-471.
5. Webb PM, Purdie DM, Grover S, et al. Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol Oncol. 2004; 92(1):232-239.
6. Twombly R. Cancer killer may be "silent" no more. J Natl Cancer Inst. 2007;99(18):1359-1361.
7. Rossing MA, Cushing-Haugen KL, Wicklund KG, et al. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2548-2556.
8. Fritz AG, Percy C, Andrew J, et al. International Classifcation of Diseases for Oncology ICD-O. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
9. Waksberg J. Random digit dialing sampling for case-control studies. In: Gail MH, Benichou J, eds. Encyclopedia of Epidemiologic Methods. New York, NY: John Wiley & Sons; 2000:749-753.
10. Tavassoli FA, Devilee P. World Health Organization Classifcation of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003.
11. Shih IM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164(5): 1511-1518.
12. Weiss NS. Clinical Epidemiology: The Study of the Outcome of Illness. 2nd ed. New York, NY: Oxford University Press; 1996.
13. Buys SS, Partridge E, Greene MH, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: fndings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193(5):1630-1639. (Pubitemid 41540458)
14. Jacobs I, Davies AP, Bridges J, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultraso-nography. BMJ. 1993;306(6884):1030-1034.
15. Attanucci CA, Ball HG, Zweizig SL, et al. Differences in symptoms between patients with benign and malignant ovarian neoplasms. Am J Obstet Gynecol. 2004;190(5):1435-1437.
16. Eltabbakh GH, Yadav PR, Morgan A. Clinical picture of women with early stage ovarian cancer. Gynecol Oncol. 1999;75(3):476-479.
17. Friedman GD, Skilling JS, Udaltsova NV, et al. Early symptoms of ovarian cancer: a case-control study without recall bias. Fam Pract. 2005;22(5):548-553.
18. Goff BA, Mandel L, Muntz HG, et al. Ovarian carcinoma diagnosis. Cancer. 2000;89(10):2068-2075.
19. Lataifeh I, Marsden DE, Robertson G, et al. Presenting symptoms of epithelial ovarian cancer. Aust N Z J Obstet Gynaecol. 2005;45(3): 211-214.
20. Ryerson AB, Eheman C, Burton J, et al. Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer. Obstet Gynecol. 2007;109(5):1053-1061.
21. Smith LH, Morris CR, Yasmeen S, et al. Ovarian cancer: can we make the clinical diagnosis earlier? Cancer. 2005;104(7):1398-1407.
22. Vine MF, Calingaert B, Berchuck A, et al. Characterization of prediagnos-tic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol. 2003;90(1):75-82.
23. Wynn ML, Chang S, Peipins LA. Temporal patterns of conditions and symptoms potentially associated with ovarian cancer. J Womens Health (Larchmt). 2007;16(7):971-986.
24. Kurman RJ, Shih I. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27(2):151-160.